Key Takeaways
N07.9 is a billable ICD-10-CM code for hereditary nephropathy, not elsewhere classified, with unspecified morphological changes
The 2026 edition became effective October 1, 2025 – verify the current fiscal year edition before submitting claims
N07 (parent code) is non-billable – always submit N07.9 or a more specific subcategory; using the parent code triggers automatic rejection
Pabau’s claims management software flags non-billable parent codes at submission, preventing N07 denials before they reach the payer
ICD-10 Code N07.9 is a billable ICD-10-CM code for hereditary nephropathy, not elsewhere classified (NEC), with unspecified morphological changes. It’s the correct choice when a patient’s hereditary nephropathy is documented without a specified histological pattern – a common scenario when biopsy results are pending or histology hasn’t been performed. Submitting the non-billable parent code N07 instead of this subcategory is the most frequent reason these claims come back rejected.
This reference covers ICD-10 Code N07.9 billable status, the full N07 subcategory table, Excludes2 conditions, coding guidelines for sequencing with chronic kidney disease (CKD), documentation requirements, and the ICD-9-CM crosswalk for legacy record conversion.
ICD-10 Code N07.9: Definition and code details
ICD-10 Code N07.9 is a billable, specific ICD-10-CM code used to indicate a diagnosis of hereditary nephropathy, not elsewhere classified (NEC), with unspecified morphological changes. According to the Centers for Medicare and Medicaid Services (CMS), the 2026 edition became effective on October 1, 2025. The code sits within the glomerular diseases block (N00-N08) of Chapter 14, which covers diseases of the genitourinary system in the ICD-10-CM classification maintained by the CDC/NCHS.
“Not elsewhere classified” (NEC) signals that the underlying hereditary nephropathy does not fit a more specific code in the classification. “Unspecified morphological changes” means the medical record does not document a particular histological pattern – such as focal and segmental glomerular lesions or diffuse mesangial proliferation – that would justify a more specific N07.x subcode. Accurate use of ICD-10 Code N07.9 depends on understanding both of these qualifiers before assigning the code, which is why EHR integration with real-time code validation reduces costly misassignments.
Understanding the N07 ICD-10-CM category
N07 is the non-billable parent code for hereditary nephropathy, not elsewhere classified. The WHO ICD-10 classification organizes hereditary nephropathies here when they do not meet criteria for more specific hereditary renal disease categories. Because N07 alone cannot be submitted for reimbursement, coders must select a subcategory based on the morphological change documented in the medical record.
N07.9 is the correct choice when the medical record is silent on histological pattern. When biopsy results are available, a more specific subcode – N07.0 through N07.8 or the newer alphanumeric subcodes – should be assigned instead. Understanding the full sibling code table is essential for coders handling nephrology claims and supports accurate claims management workflows.

N07 subcategory codes: Full sibling code table
Excludes notes for N07.9: What this code does not cover
The N07 category carries Excludes2 notes for four related hereditary and metabolic kidney conditions. An Excludes2 note means “not included here” – the excluded condition is classified under its own, more specific code rather than N07.9, but coding guidelines do not prohibit reporting N07.9 alongside it when the record documents both an unspecified hereditary nephropathy and one of these named conditions.
Coders should still default to the more specific code whenever the physician documents Alport syndrome, hereditary amyloid nephropathy, non-neuropathic heredofamilial amyloidosis, or nail patella syndrome by name – reflexively assigning N07.9 instead is the more common error. Refer to the AAPC ICD-10-CM code lookup or the official CDC tool when verifying exclusion applicability for individual patient encounters.
- Hereditary amyloid nephropathy (E85.-): Amyloidosis codes are assigned from the E85 block (endocrine, nutritional, and metabolic diseases). When amyloid deposition is the documented cause of the nephropathy, assign the specific E85 code rather than N07.9 – the Excludes2 note doesn’t stop N07.9 from also being reported if the record separately documents an unspecified hereditary nephropathy.
- Non-neuropathic heredofamilial amyloidosis (E85.-): Also assigned from the E85 block, this is a distinct hereditary amyloidosis subtype from hereditary amyloid nephropathy. As with the condition above, documenting it by name doesn’t block N07.9 from also being reported when the record separately supports an unspecified hereditary nephropathy.
- Alport syndrome (Q87.81): Alport syndrome is a hereditary nephritis characterized by hearing loss and ocular abnormalities with a known genetic mutation. When it’s documented by name, Q87.81 is the more specific code to assign – it isn’t blocked from being reported alongside N07.9 when both are clinically supported.
- Nail patella syndrome (Q87.2): Hereditary onycho-osteodysplasia, which includes renal involvement, is coded Q87.2. Defaulting to N07.9 when nail patella syndrome is documented misses the more specific code, even though the two aren’t mutually exclusive under Excludes2 rules.
Alport syndrome vs. N07.9: Coding distinction
Alport syndrome is among the most common hereditary nephropathies encountered in clinical practice, and defaulting to N07.9 when it’s documented is a recurring audit finding. The distinction matters because Alport syndrome (Q87.81) reflects a confirmed genetic diagnosis – typically a COL4A3, COL4A4, or COL4A5 mutation. N07.9 covers hereditary nephropathy where the underlying cause hasn’t been genetically characterized or otherwise specified.
When a physician documents “Alport syndrome” in the clinical note, Q87.81 is the more specific code to assign regardless of the morphological pattern seen on biopsy. Because the N07 exclusion note is an Excludes2, not an Excludes1, coding guidelines don’t prohibit N07.9 from also appearing on the same claim if the record separately documents an unspecified hereditary nephropathy alongside the Alport diagnosis.
Pro Tip
Before assigning N07.9, run a quick documentation check: does the physician note mention Alport syndrome, amyloidosis, or nail patella syndrome by name? If yes, assign the more specific code (Q87.81, E85.-, or Q87.2) for that diagnosis instead of defaulting to N07.9. These are Excludes2 notes, not Excludes1 – so N07.9 isn’t banned from the same claim if the documentation separately supports an unspecified hereditary nephropathy alongside the named condition.
ICD-10-CM coding guidelines for N07.9
Applying ICD-10 Code N07.9 correctly requires more than confirming billable status. The ICD-10-CM official coding guidelines govern sequencing, specificity, and documentation requirements that affect claim acceptance. Practices that invest in HIPAA-compliant medical office workflows and structured clinical documentation tend to have lower denial rates on complex renal codes.
Documentation requirements to support N07.9
For a coder to assign N07.9 defensibly, the physician’s documentation should include at least three elements. These are the minimum standards coders should query for when the record is incomplete:
- Explicit diagnosis statement: The attending physician must document “hereditary nephropathy” or an equivalent clinical term. Coders cannot infer hereditary origin from family history alone.
- Absence of specified morphology: The record should indicate that biopsy was not performed, results are pending, or the morphological pattern was not otherwise specified. This justifies .9 over a more specific subcode.
- Exclusion of Alport syndrome and amyloidosis: When hereditary nephropathy is documented, the physician’s note should indicate whether a genetic workup was pursued. If Alport syndrome is documented anywhere, Q87.81 must be used instead. Detailed patient record documentation makes this audit trail clear.
Sequencing N07.9 with chronic kidney disease codes
Hereditary nephropathy frequently co-exists with chronic kidney disease (CKD), a comorbidity that shows up as often in primary care software as it does in dedicated metabolic health workflows. When both are documented, sequencing depends on the reason for the encounter. Per ICD-10-CM guidelines:
- Hereditary nephropathy as the principal diagnosis: Sequence N07.9 first when the encounter is specifically for hereditary nephropathy evaluation, genetic counseling, or nephrology consultation focused on the hereditary condition. The CKD stage code follows as an additional diagnosis.
- CKD as the principal diagnosis: When the encounter is for CKD management – dialysis access, CKD progression monitoring, or renal replacement therapy planning – sequence the CKD stage code (N18.1 through N18.6) first, with N07.9 as an additional code to capture the underlying cause.
- Both equally responsible for the admission: If the record does not clearly indicate which condition drove the encounter, coding guidelines permit either sequencing. Query the physician for clarification whenever possible – the same sequencing logic applies whenever a claim pairs a hereditary or chronic diagnosis with a code like K26.0.
Stop N07 rejections before they reach the payer
Pabau's claims management module flags non-billable parent codes at submission, so your team catches N07 vs. N07.9 errors before the claim leaves the practice. See how integrated coding validation supports your billing workflow.
ICD-9-CM to ICD-10-CM crosswalk for hereditary nephropathy
Practices converting historical records or handling appeals on legacy claims sometimes look for a single ICD-9-CM equivalent of N07.9 – but hereditary nephropathy, NEC didn’t crosswalk cleanly from ICD-9. A commonly repeated shortcut treats ICD-9-CM 583.9 (nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney) as the legacy match for N07.9 – the same kind of assumption trips up crosswalk lookups for other codes, including M34.2. That’s incorrect: per the CMS General Equivalence Mappings (GEMs), 583.9 maps forward to N05.9 (unspecified nephritic syndrome with unspecified morphologic changes), not to N07.9. The table below shows that mapping so practices don’t misapply it to hereditary nephropathy claims.
When handling pre-2015 records, confirm any crosswalk against the official GEMs file published by CMS rather than relying on a single remembered code pair. ICD-9-CM didn’t isolate hereditary nephropathy, NEC at the same level of specificity as the current ICD-10-CM N07.x subcategory structure, so there isn’t a dedicated one-to-one legacy match for N07.9 – coders converting historical hereditary nephropathy documentation should map from the clinical detail in the chart rather than from 583.9. Practices using modern EMR software with coding support can automate this lookup for historical data migration.
Pro Tip
Check the record date before applying the crosswalk. Claims with dates of service before October 1, 2015 use ICD-9-CM codes. Claims from October 1, 2015 onward require ICD-10-CM. Mixing code sets based on service date is one of the most common errors in legacy record conversions.
Conclusion
ICD-10 Code N07.9 is the correct code when hereditary nephropathy is documented without a specified morphological pattern and none of the more specific Excludes2 conditions – Alport syndrome, hereditary amyloid nephropathy, non-neuropathic heredofamilial amyloidosis, or nail patella syndrome – are the documented cause. The most common errors – using the non-billable parent N07, defaulting to N07.9 when a more specific diagnosis is named, and sequencing CKD incorrectly – are preventable with thorough documentation review before submission.
Pabau’s claims management software validates code-level specificity at submission, flagging non-billable parent codes so your team catches N07 errors before they reach the payer. To see how integrated coding validation fits into your billing workflow, book a demo.
Continue your research
Need a structured approach to renal billing workflows? Practice management software explains how integrated platforms reduce coding errors across specialties.
Need another example of a billable diagnostic code with its own documentation quirks? R81 covers glycosuria coding and documentation requirements.
Looking to tighten your clinical documentation standards? Safer clinical notes guide covers documentation best practices that support defensible code assignment.
Frequently asked questions
What is ICD-10 Code N07.9 used for?
ICD-10 Code N07.9 is a billable diagnosis code used to indicate hereditary nephropathy, not elsewhere classified, with unspecified morphological changes. It applies when a patient has a documented hereditary nephropathy that does not fit a more specific category and when the medical record does not specify a histological pattern from renal biopsy.
Is N07.9 a billable ICD-10-CM code?
Yes. N07.9 is a billable, specific ICD-10-CM code valid for claim submission and reimbursement. The 2026 edition became effective October 1, 2025. The parent code N07 is not billable and cannot be submitted for reimbursement.
What is the difference between N07 and N07.9?
N07 is the non-billable parent category code for hereditary nephropathy, not elsewhere classified. N07.9 is the billable subcategory code used specifically when the morphological changes are unspecified. Claims submitted with N07 will be rejected; N07.9 (or another specific N07.x subcode) is required for reimbursement.
What conditions are excluded from ICD-10 Code N07.9?
Four conditions are excluded via Excludes2 notes: hereditary amyloid nephropathy (coded E85.-), non-neuropathic heredofamilial amyloidosis (coded E85.-), Alport syndrome (coded Q87.81), and nail patella syndrome with renal involvement (coded Q87.2). An Excludes2 note means these conditions are classified under their own, more specific code rather than N07.9 – it does not prohibit reporting N07.9 alongside them when the record documents both an unspecified hereditary nephropathy and one of these more specific diagnoses.
How does N07.9 differ from Alport syndrome coding?
Alport syndrome is coded Q87.81, a more specific code than N07.9. Alport syndrome is a genetically confirmed hereditary nephritis – typically involving a COL4A mutation – and is listed as an Excludes2 condition under N07. When a physician documents Alport syndrome in the clinical note, Q87.81 should be assigned regardless of the morphological findings on biopsy, though coding rules don’t prevent N07.9 from also being reported if the chart separately documents an unspecified hereditary nephropathy.
What is the ICD-9-CM equivalent of N07.9?
There isn’t a single clean ICD-9-CM equivalent. ICD-9-CM 583.9 is sometimes assumed to be the match, but per the CMS General Equivalence Mappings it forward-maps to N05.9 (unspecified nephritic syndrome), not to N07.9. ICD-9-CM didn’t isolate hereditary nephropathy at the same specificity as the current N07.x subcategories, so legacy record conversions should be based on the clinical documentation rather than a single crosswalk code – confirm against the official CMS GEM file for individual claim appeals.
When should N07.9 be sequenced before a CKD code?
Sequence N07.9 as the principal diagnosis when the encounter is specifically for hereditary nephropathy evaluation, genetic counseling, or nephrology consultation focused on the hereditary condition. When the encounter is primarily for CKD management, sequence the CKD stage code (N18.x) first and list N07.9 as an additional code for the underlying cause.